The assessment of the serum levels of TWEAK and prostaglandin F2α in COVID – 19

Demet Yalçın Kehribar Mustafa Cihangiroğlu Emine Sehmen Bahattin Avci Mustafa Çapraz Maruf Boran Caner Günaydin Metin Özgen

Published in: Turkish journal of medical sciences (2020)

In the study, TWEAK and LTE4 levels increased in cases with COVID-19. These results support that TWEAK/Fn14 pathway and LT may involved in the pathology of aberrant immune response against SARS-CoV-2. Inhibition of each of these pathways may be a potential target in the treatment of COVID-19.

Keyphrases

sars cov
coronavirus disease
respiratory syndrome coronavirus
immune response
dendritic cells
combination therapy
smoking cessation